Search

Your search keyword '"Frishman, William"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Frishman, William" Remove constraint Author: "Frishman, William" Journal journal of clinical pharmacology Remove constraint Journal: journal of clinical pharmacology
105 results on '"Frishman, William"'

Search Results

1. Cardiovascular Drug Therapy in Patients with Hepatic Diseases and Patients with Congestive Heart Failure.

2. Raloxifene, a New Selective Estrogen Receptor Modulator.

3. Matrix Metalloproteinases and Abdominal Aortic Aneurysms: A Potential Therapeutic Target.

4. Alpha-Adrenergic Blocking Drugs in Clinical Medicine.

5. Sodium Ion/Hydrogen Ion Exchange Inhibition: A New Pharmacologic Approach to Myocardial Ischemia and Reperfusion Injury.

6. Use of Angiotensin-Converting Enzyme Inhibitors as Monotherapy and in Combination with Diuretics and Calcium Channel Blockers.

7. The Sodium-Calcium Ion Membrane Exchanger: Physiologic Significance and Pharmacologic Implications.

8. Innovative Drug Treatments for Viral and Autoimmune Myocarditis.

9. Chelation Therapy in Cardiovascular Disease: Ethylenediaminetetraacetic Acid, Deferoxamine, and Dexrazoxane.

10. Matrix Metalloproteinases and Coronary Artery Disease: A Novel Therapeutic Target.

11. Fenoldopam: A New Dopamine Agonist for the Treatment of Hypertensive Urgencies and Emergencies.

12. The Pharmacologic Approach to the Treatment of Obesity.

13. Nicorandil: A Potassium Channel Opening Drug for Treatment of Ischemic Heart Disease.

14. Imidazoline Receptor Agonist Drugs: A New Approach to the Treatment of Systemic Hypertension.

15. Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.

16. Insulin Resistance in Systemic Hypertension: Pharmacotherapeutic Implications.

17. Management of Hypertensive Urgencies and Emergencies.

18. Serotonin and Serotonin Antagonism in Cardiovascular and Non-Cardiovascular Disease.

19. Clinical Pharmacology of Estrogens: Cardiovascular Actions and Cardioprotective Benefits of Replacement Therapy in Postmenopausal Women.

20. First-Line Therapy Option with Low-Dose Bisoprolol Fumarate and Low-Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic Hypertension.

21. Atrial Natriuretic Peptide and Its Potential Role in Pharmacotherapy.

22. Calcium-Channel Entry Blocker Therapy for Hypertensive Patients with Concomitant Renal Impairment: A Focus on Isradipine.

23. Adverse Dermatologic Reactions from Antiarrhythmic Drug Therapy.

24. Renin Inhibition: A New Approach to Cardiovascular Therapy.

25. Topical Ophthalmic β-Adrenergic Blockade for the Treatment of Glaucoma and Ocular Hypertension.

26. Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular Pharmacotherapy.

27. Combination Drug Therapy with Calcium-Channel Blockers in the Treatment of Systemic Hypertension.

28. A New Extended-Release Formulation of Diltiazem HCl for the Treatment of Mild-to-Moderate Hypertension.

29. Nisoldipine: A New Dihydropyridine Calcium-Channel Blocker.

30. Sustained-Release Verapamil Formulations for Treating Hypertension.

31. Antihypertensive and Metabolic Effects of Concomitant Administration of Terazosin and Methyclothiazide for the Treatment of Essential Hypertension.

32. Neutral Endopeptidase Inhibitors and Atrial Natriuretic Peptide.

33. Nicotinic Acid for the Treatment of Hyperlipoproteinemia.

34. Effects of Gemfibrozil and Other Fibric Acid Derivatives on Blood Lipids and Lipoproteins.

35. Betaxolol: A New Long-Acting Beta1-Selective Adrenergic Blocker.

36. Dietary Fiber for Reducing Blood Cholesterol.

37. Co-Enzyme Q10: A New Drug for Cardiovascular Disease.

38. Penbutolol and Carteolol: Two New Beta-Adrenergic Blockers with Partial Agonism.

39. Rapid-Acting Parenteral Antihypertensive Agents.

40. Bile Acid Sequestrants.

41. Probucol: Pharmacology and Clinical Application.

42. Sustained High-Dose Nitroglycerin Transcutaneous Patch Therapy in Angina Pectoris: Evidence for Attenuation of Effect Over Time.

43. Dilevalol: A Selective Beta-2 Adrenergic Agonist Vasodilator with Beta Adrenergic Blocking Activity.

44. New Therapeutic Modalities in Hypertension: Focus on a New Calcium Antagonist-Nicardipine.

46. Clinical Utility of Nifedipine and Diltiazem Plasma Levels in Patients with Angina Pectoris Receiving Monotherapy and Combination Treatment.

47. Labetalol Compared with Propranolol in Patients with Both Angina Pectoris and Systemic Hypertension: A Double-Blind Study.

48. Serotonergic Blockade Compared with Beta-Adrenergic Blockade in Systemic Hypertension: A Double-Blind Comparison of Ketanserin with Propranolol.

49. Hemodynamic Effects of Flestolol, a Titratable Short-Acting Intravenous Beta-Adrenergic Receptor Blocker.

50. Co‐Enzyme Q10: A New Drug for Cardiovascular Disease

Catalog

Books, media, physical & digital resources